Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -22,206 | N/A | N/A |
| Depreciation Amortization | 831 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,721 | N/A | N/A |
| Other Working Capital | -3,679 | N/A | N/A |
| Other Operating Activity | 2,454 | 0 | 0 |
| Operating Cash Flow | $-24,321 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -771 | N/A | N/A |
| Investing Cash Flow | $-771 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 163 | N/A | N/A |
| Other Financing Activity | 9,873 | 0 | 0 |
| Financing Cash Flow | $10,036 | $N/A | $N/A |
| Beginning Cash Position | 32,543 | N/A | N/A |
| End Cash Position | 17,487 | N/A | N/A |
| Net Cash Flow | $-15,056 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -24,321 | N/A | N/A |
| Capital Expenditure | -771 | N/A | N/A |
| Free Cash Flow | -25,092 | 0 | 0 |